The Biden administration proposed a rule for Medicare and Medicaid to cover the costs of weight-loss drugs for millions of ...

WASHINGTON — The Biden administration announced last Tuesday it’s reinterpreting federal law to allow Medicare and Medicaid patients access to anti-obesity medications to reduce their weight over the ...

While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

Self-stigma was associated with higher dropout rates, engagement, and weight loss among individuals who completed a weight loss program.

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered ...

West Virginia’s Public Employee Insurance Agency (PEIA) is in a bind.  Medical inflation continues to drive up health care costs and the PEIA finance board is looking for ways to save money while ...

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...